Moss, MD, R. B., Carleton, PhD, F., Lollo, PhD, C. P. and Carlo, PhD, D. J. (2020) “An open-label, randomized, single-dose, two-period, two-treatment crossover bioavailability study comparing 5 mg/0.5 mL of intramuscular naloxone hydrochloride to 2 mg/0.4 mL intramuscular naloxone hydrochloride autoinjector in healthy subjects”, Journal of Opioid Management, 16(3), pp. 209–214. doi: 10.5055/jom.2020.0569.